CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Getinge B - GETIb CFD

251.5
1.13%
1.0
Low: 241.3
High: 251.9
Market Trading Hours* (UTC) Opens on Tuesday at 07:00

Mon - Fri: 07:00 - 15:25

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 1.0
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.019721 %
Charges from borrowed part ($-0.79)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.019721%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.002501 %
Charges from borrowed part ($-0.10)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.002501%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency SEK
Margin 20%
Stock exchange Sweden
Commission on trade 0%

*Information provided by Capital.com

Getinge AB ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 248.7
Open* 245.6
1-Year Change* -12.75%
Day's Range* 241.3 - 251.9
52 wk Range 178.40-289.80
Average Volume (10 days) 760.52K
Average Volume (3 months) 15.46M
Market Cap 64.55B
P/E Ratio 27.20
Shares Outstanding 272.37M
Revenue 29.25B
EPS 9.34
Dividend (Yield %) 1.67323
Beta 0.96
Next Earnings Date Jul 18, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 2, 2023 248.7 -4.5 -1.78% 253.2 268.4 235.2
Jun 1, 2023 251.2 0.0 0.00% 251.2 253.6 245.5
May 31, 2023 248.5 -1.2 -0.48% 249.7 253.8 248.3
May 30, 2023 251.7 0.0 0.00% 251.7 255.0 251.1
May 29, 2023 251.4 -1.9 -0.75% 253.3 255.1 250.1
May 26, 2023 252.9 4.2 1.69% 248.7 253.7 246.9
May 25, 2023 249.2 -3.4 -1.35% 252.6 254.8 248.5
May 24, 2023 253.6 3.7 1.48% 249.9 257.5 246.5
May 23, 2023 251.0 -2.5 -0.99% 253.5 255.3 250.8
May 22, 2023 254.1 -2.3 -0.90% 256.4 257.1 252.6
May 19, 2023 258.2 5.7 2.26% 252.5 258.9 252.5
May 17, 2023 252.0 4.5 1.82% 247.5 252.6 247.5
May 16, 2023 252.0 -1.4 -0.55% 253.4 255.6 251.2
May 15, 2023 254.6 6.5 2.62% 248.1 255.2 248.1
May 12, 2023 247.5 -1.7 -0.68% 249.2 250.2 246.7
May 11, 2023 249.5 6.3 2.59% 243.2 250.2 241.9
May 10, 2023 243.1 -2.9 -1.18% 246.0 246.7 241.6
May 9, 2023 245.6 -4.1 -1.64% 249.7 249.8 244.3
May 8, 2023 249.8 -0.8 -0.32% 250.6 251.6 248.5
May 5, 2023 251.6 -0.7 -0.28% 252.3 252.4 250.0

Getinge B Events

Time (UTC) Country Event
Tuesday, July 18, 2023

Time (UTC)

06:00

Country

SE

Event

Q2 2023 Getinge AB Earnings Release
Q2 2023 Getinge AB Earnings Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

SE

Event

Q2 2023 Getinge AB Earnings Call
Q2 2023 Getinge AB Earnings Call

Forecast

-

Previous

-
Monday, October 23, 2023

Time (UTC)

06:00

Country

SE

Event

Q3 2023 Getinge AB Earnings Release
Q3 2023 Getinge AB Earnings Release

Forecast

-

Previous

-

Time (UTC)

10:59

Country

SE

Event

Q3 2023 Getinge AB Earnings Call
Q3 2023 Getinge AB Earnings Call

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 28292 27049 29819 26559 24172
Revenue 28292 27049 29819 26559 24172
Cost of Revenue, Total 14882 13469 15097 14104 13119
Gross Profit 13410 13580 14722 12455 11053
Total Operating Expense 24666 22678 25035 24187 24456
Selling/General/Admin. Expenses, Total 7484 6972 7596 7681 7312
Research & Development 1013 804 770 688 662
Depreciation / Amortization 1074 1002 1450 1247 1009
Unusual Expense (Income) 235 96 177 324 0
Other Operating Expenses, Total -44 335 -55 143 2354
Operating Income 3626 4371 4784 2372 -284
Interest Income (Expense), Net Non-Operating -131 -142 -257 -408 -309
Other, Net -23 -41 -42 -55 -31
Net Income Before Taxes 3472 4188 4485 1909 -624
Net Income After Taxes 2516 3001 3272 1256 -1132
Minority Interest -25 -31 -34 -34 -28
Net Income Before Extra. Items 2491 2970 3238 1222 -1160
Total Extraordinary Items 193
Net Income 2491 2970 3238 1222 -967
Income Available to Common Excl. Extra. Items 2491 2970 3239 1222 -1160
Income Available to Common Incl. Extra. Items 2491 2970 3239 1222 -967
Diluted Net Income 2491 2970 3239 1222 -967
Diluted Weighted Average Shares 272.37 272.37 272.37 272.37 272.37
Diluted EPS Excluding Extraordinary Items 9.14565 10.9043 11.8919 4.48655 -4.25892
Dividends per Share - Common Stock Primary Issue 4.25 4 3 1.5 1
Diluted Normalized EPS 12.1308 13.9009 14.5142 5.66778 -3.9797
Total Adjustments to Net Income 0 1
Interest Expense (Income) - Net Operating 22
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 7141 8499 6941 6670 6182
Revenue 7141 8499 6941 6670 6182
Cost of Revenue, Total 3622 4671 3561 3521 3129
Gross Profit 3519 3828 3380 3149 3053
Total Operating Expense 6240 7671 5834 5759 5402
Selling/General/Admin. Expenses, Total 2061 2013 1865 1820 1787
Research & Development 282 275 242 254 242
Depreciation / Amortization 245 367 245 231 230
Unusual Expense (Income) 20 202 14 2 17
Other Operating Expenses, Total 10 143 -93 -69 -3
Operating Income 901 828 1107 911 780
Interest Income (Expense), Net Non-Operating -75 -47 -31 -44 -32
Other, Net -1 1
Net Income Before Taxes 826 781 1075 867 749
Net Income After Taxes 593 561 805 612 539
Minority Interest -7 -5 -7 -8 -5
Net Income Before Extra. Items 586 556 798 604 534
Net Income 586 556 798 604 534
Income Available to Common Excl. Extra. Items 586 556 798 603 534
Income Available to Common Incl. Extra. Items 586 556 798 603 534
Diluted Net Income 586 556 798 603 534
Diluted Weighted Average Shares 272.37 272.37 272.37 272.37 272.37
Diluted EPS Excluding Extraordinary Items 2.15149 2.04134 2.92984 2.2139 1.96057
Dividends per Share - Common Stock Primary Issue 0 4.25 0 0 0
Diluted Normalized EPS 2.21211 3.178 2.96833 2.21908 2.00813
Total Adjustments to Net Income -1 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 19106 15069 17431 14494 14148
Cash and Short Term Investments 5747 4078 6079 1266 1290
Cash & Equivalents 5676 4076 6056 1254 1273
Short Term Investments 71 2 23 12 17
Total Receivables, Net 6703 5941 6606 8212 7988
Accounts Receivable - Trade, Net 5954 5209 5854 7317 6969
Total Inventory 6232 4767 4513 4691 4544
Prepaid Expenses 423 283 233 325 326
Total Assets 52032 44555 45014 44713 43352
Property/Plant/Equipment, Total - Net 4868 4120 3973 4087 3160
Property/Plant/Equipment, Total - Gross 12079 10493 9274 9446 8223
Accumulated Depreciation, Total -7212 -6372 -5303 -5359 -5063
Goodwill, Net 22512 19681 17427 18674 18092
Intangibles, Net 4498 4467 4658 5609 6006
Long Term Investments 0 2 15 0
Note Receivable - Long Term 50 52 50 32 80
Other Long Term Assets, Total 998 1166 1473 1802 1866
Total Current Liabilities 11993 10610 9788 9864 10005
Accounts Payable 2252 1921 1446 1995 1868
Accrued Expenses 2348 2608 2699 2130 1960
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 793 811 2519 2952 3451
Other Current Liabilities, Total 6600 5270 3124 2787 2726
Total Liabilities 21994 19805 23990 24217 24151
Total Long Term Debt 5031 3495 7687 7068 7378
Long Term Debt 4100 2795 7020 6487 7378
Deferred Income Tax 1150 897 829 661 693
Minority Interest 415 427 462 477 454
Other Liabilities, Total 3405 4376 5224 6147 5621
Total Equity 30038 24750 21024 20496 19201
Common Stock 136 136 136 136 136
Additional Paid-In Capital 6789 6789 6789 6789 6789
Retained Earnings (Accumulated Deficit) 23113 17824 14099 13571 12276
Total Liabilities & Shareholders’ Equity 52032 44555 45014 44713 43352
Total Common Shares Outstanding 272.37 272.37 272.37 272.37 272.37
Capital Lease Obligations 931 700 667 581
Other Equity, Total 1
Other Current Assets, Total 1
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 17909 19106 17671 16356 15482
Cash and Short Term Investments 4625 5676 4839 4147 4319
Cash & Equivalents 4625 5676 4839 4147 4319
Total Receivables, Net 6497 7198 6366 6302 5867
Accounts Receivable - Trade, Net 4599 5275 4435 4276 4085
Total Inventory 6787 6232 6466 5907 5296
Total Assets 50985 52032 51907 48480 45451
Property/Plant/Equipment, Total - Net 4954 4868 4790 4613 4210
Intangibles, Net 27069 27010 28327 26389 24613
Long Term Investments 59 1048 1119 1122 1145
Total Current Liabilities 9520 11993 7821 7487 7338
Accounts Payable 2098 2252 1902 1964 1946
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 793
Other Current Liabilities, Total 7422 8948 5919 5523 5392
Total Liabilities 20352 21994 21455 20660 19364
Total Long Term Debt 5816 5031 5499 5389 4290
Long Term Debt 4421 4100 4209 4103 3197
Capital Lease Obligations 1395 931 1290 1286 1093
Minority Interest 426 415 455 454 437
Other Liabilities, Total 3369 3405 7680 7330 7299
Total Equity 30633 30038 30452 27820 26087
Common Stock 136 136 136 136 136
Additional Paid-In Capital 6789 6789 6789 6789 6789
Retained Earnings (Accumulated Deficit) 23707 23113 23527 20894 19162
Total Liabilities & Shareholders’ Equity 50985 52032 51907 48480 45451
Total Common Shares Outstanding 272.37 272.37 272.37 272.37 272.37
Other Long Term Assets, Total 994 1
Deferred Income Tax 1221 1150
Other Equity, Total 1 0 1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 3626 4371 4784 2372 -284
Cash From Operating Activities 3367 6560 7199 3832 2503
Cash From Operating Activities 2027 1814 2467 2223 1808
Non-Cash Items -31 126 -86 -121 1866
Cash Taxes Paid 1012 693 553 357 366
Cash Interest Paid
Changes in Working Capital -2255 249 34 -642 -887
Cash From Investing Activities -1470 -1329 -1991 -1117 -1339
Capital Expenditures -1136 -930 -1045 -1220 -1380
Other Investing Cash Flow Items, Total -334 -399 -946 103 41
Cash From Financing Activities -500 -7237 -297 -2772 -1440
Financing Cash Flow Items -16 -1 -17 3 -11
Total Cash Dividends Paid -1090 -858 -433 -298 -424
Issuance (Retirement) of Stock, Net 0
Issuance (Retirement) of Debt, Net 606 -6378 153 -2477 -1005
Foreign Exchange Effects 203 26 -110 38 23
Net Change in Cash 1600 -1980 4801 -19 -253
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 901 3626 2798 1691 780
Cash From Operating Activities -427 3367 2346 1070 647
Cash From Operating Activities 460 2027 1332 875 438
Non-Cash Items -116 -31 -161 -105 -58
Cash Taxes Paid 179 1012 711 578 268
Changes in Working Capital -1672 -2255 -1623 -1391 -513
Cash From Investing Activities -441 -1470 -1088 -551 -262
Capital Expenditures -291 -1136 -815 -539 -239
Other Investing Cash Flow Items, Total -150 -334 -273 -12 -23
Cash From Financing Activities -226 -500 -749 -604 -219
Financing Cash Flow Items -9 -16 -20 -1 -1
Total Cash Dividends Paid 0 -1090 -1089 -1089 0
Issuance (Retirement) of Debt, Net -217 606 360 486 -218
Foreign Exchange Effects 43 203 255 156 78
Net Change in Cash -1051 1600 764 71 244
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Bennet (Carl) Individual Investor 14.2957 36332969 0 2022-12-31 LOW
Fjärde AP-Fonden Pension Fund 8.2314 20920184 -2594 2022-12-31 LOW
AMF Tjänstepension AB Pension Fund 5.9225 15052142 -727242 2022-12-31 LOW
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 4.9763 12647337 1223793 2022-12-31 LOW
Didner & Gerge Fonder AB Investment Advisor 3.6821 9358241 615939 2022-12-31 LOW
Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 3.1762 8072420 -740180 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.1083 7899781 276967 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.8915 7348846 -156167 2022-12-31 LOW
Incentive AS Investment Advisor/Hedge Fund 2.775 7052615 367141 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.1502 5464858 -1007885 2022-12-31 LOW
Carnegie Fonder AB Bank and Trust 1.8721 4758075 343085 2022-12-31 LOW
Folksam Group Insurance Company 1.8074 4593525 75706 2022-12-31 LOW
Storebrand Kapitalforvaltning AS Investment Advisor 1.2517 3181315 -278731 2022-12-31 LOW
Lansförsäkringar Fondförvaltning AB Investment Advisor 1.21 3075155 -83258 2022-12-31 LOW
Marathon-London Investment Advisor 1.2049 3062308 0 2022-12-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 1.0138 2576690 82250 2023-04-30 LOW
Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.9098 2312250 0 2023-04-30 LOW
Cliens Asset Management AB Investment Advisor 0.8814 2240000 -495000 2022-12-31 LOW
Första AP-Fonden Pension Fund 0.8004 2034127 -54178 2022-12-31 LOW
SEB Investment Management AB Investment Advisor 0.7186 1826292 -194048 2022-12-31 LOW

Start a global, multi-asset portfolio with an award-winning platform

Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Getinge Company profile

About Getinge AB

Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, GetingeAB revenues decreased 9% to SEK27.05B. Net incomeapplicable to common stockholders decreased 8% to SEK2.97B.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Net income also reflects Research & Development Expenditure, Cap decrease of 19% to SEK346M (income), Acquisitionexpenses increase from SEK8M to SEK35M (expense).

Equity composition

April 2001: Bonus Issue, adjustment factor 0.9717.November 2003: Stock Split in the ratio 1:4. 02/2008,Rights Issue, 1 new share for every 16 shares held @ SEK120 (Factor: 1.014783). 11/2008, Rights Issue, 1 new sharefor every 9 shares held @ SEK 83.5 (Factor: 1.01930).

Industry: Medical Equipment

Lindholmspiren 7
P.O. Box 8861
GOETEBORG
VASTRA GOTALANDS 417 56
SE

Income Statement

  • Annual
  • Quarterly

People also watch

Gold

1,962.52 Price
+0.740% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

0.50 Price
-8.130% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00391

BTC/USD

25,537.10 Price
-6.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

US100

14,566.50 Price
+0.100% 1D Chg, %
Long position overnight fee -0.0255%
Short position overnight fee 0.0032%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading